Skip to main content
. 2014 Dec 3;17(2):389–399. doi: 10.1208/s12248-014-9690-8

Table II.

TMDD Model Estimated Parameter for the mAbs 1–6

Drug Parameters
Species R 0 (nM) K D (nM) K el (day−1) V c (L) K pt (day−1) K tp (day−1) K int (day−1) K deg (day−1)
mAb-1 (Efalizumab) Chimpanzees 6.11 (25) 0.427 (12) 0.123 (11) 2.92 (11) 0.395 (24) 0.383 (8) 3.17 (9) 0.303 (8)
Patients 5.41 (13) 0.516 (21) 0.112 (11) 4.47 (9) 0.286 (18) 0.506 (11) 2.06 (9) 0.597 (6)
mAb-2
(TRX-1)
Baboons 32.4 (27) 398 (75) 2.04 (69) 0.931 (17) 0.84 (106) 4.57 (143) 2.04 (69) 1.46 (74)
Healthy volunteers 28.4 (24) 30.1 (15) 4.25 (12) 3.79 (11) 0.14 (100) 0.413 (85) 4.25 (12) 0.867 (14)
mAb-3 (MTRX-1011A) Baboons 34.3 (fixed) 398 (fixed) 0.116 (19) 0.61 (20) 2.62 (26) 9.4 (68) 0.103 (31) 0.069 (32)
Patients 18.7 (10) 42.4 (10) 0.109 (7) 2.85 (16) 0.549 (13) 1.35 (21) 5.17 (4) 1.35 (2)
mAb-4 Cynomolgus monkeys 5.49 (52) 0.707 (1) 0.115 (17) 0.089 (5) 0.159 (26) 0.155 (32) 2.23 (51) 2.5 (56)
Healthy volunteers 1.62 (7) 0.381 (20) 0.0693 (12) 3.39 (2) 0.031 (19) 0.046 (41) 0.441 (10) 4.42 (4)
mAb-5 Cynomolgus monkeys 2.72 (16) 0.294 (18) 0.08 (30) 0.184 (4) 2.56 (8) 9.14 (18) 0.579 (36) 2.47 (27)
Patients 1.57 (11) 0.153 (36) 0.06 (7) 3.53 (4) 0.115 (30) 0.159 (25) 0.014 (49) 0.351 (30)
mAb-6 Cynomolgus monkeys 145 (48) 59 (62) 0.565 (31) 0.119 (44) 1.47 (46) 1.32 (30) 8.83 (22) 0.251 (11)
Healthy volunteers 130 (31) 5.61 (39) 0.221 (135) 1.6 (22) 1.32 (32) 0.341 (49) 1.83 (15) 0.239 (23)

Mean parameters for each species are provided along with %relative standard error (%RSE) in parenthesis

R 0 baseline target levels, K D equilibrium binding constant, K el central elimination rate constant, V c central volume of distribution, K pt central to peripheral distribution rate constant, K tp peripheral to central rate constant, K deg target turnover rate constant, K int complex turnover rate constant